Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: celeryroot.com who wrote (19084)	4/14/1998 10:09:00 PM
From: Henry Niman	Read Replies (1) of 32384

LLY has always had an interest in San Diego Biotechs. It's Hybritech buyout really laid the foundation for the sector's growth in San Diego. If they did an AMLN deal they could use the same parking lot to visit AMLN and LGND. LLY of course is very interested in diabetes. I assumed that they were moving toward oral treatments and I really haven't heard much about AMLN's move in that direction. I thought that Pramlintide looked pretty iffy for type II, but LLY may be more interested in Type I than JNJ was. Something is clearly driving the price and a new deal is certainly a topic that could very easily move AMLN's price. I guess if Jesse Eisinger writes a story, it will be official.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next